Walk In Drive for BPharm, MSc at Mankind Pharma
3 January 2026

Walk In Drive for BPharm, MSc at Mankind Pharma - experience candidates can apply

The candidate must be capable of analyzing raw materials, finished products, and stability samples. Knowledge of AMV and QAMS will be given preference.
3 January 2026
Aurigene looking for DMPK Scientist - M.Pharm, MSc Apply
Experience in the development and application of pharmacometric models to support drug development and regulatory submissions.
3 January 2026
Abbott Hiring TPMQA India Head
Responsible and accountable for the oversight of quality operations and GMP compliance across the TPMs under responsibility of EPD Biosimilars Operations in India.
3 January 2026
Axsome Therapeutics secures FDA priority review for Alzheimer’s agitation treatment AXS-05

Axsome Therapeutics announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s supplemental New Drug Application (sNDA) for AXS-05 seeking approval for the treatment of agitation associated with Alzheimer’s disease, and has granted Priority Review designation to the filing. The regulatory body has set a Prescription Drug User Fee Act (PDUFA) target action date of April 30, 2026, underlining the importance of this potential new therapy in an area of high unmet need.

3 January 2026
Caplin Point strengthens U.S. footprint with strategic acquisition of 10 approved ANDAs
Caplin Point Laboratories Limited has announced a major strategic move to expand its presence in the regulated U.S. pharmaceutical market by acquiring ten approved Abbreviated New Drug Applications (ANDAs) for injectable and ophthalmic products from a leading multinational generic pharmaceuticals manufacturer.
3 January 2026
U.S. drugmakers set to increase prices on hundreds of medicines despite Federal pushback
U.S. drugmakers are preparing to raise the list prices of hundreds of brand-name medicines in 2026, despite growing pressure from Washington to curb prescription drug costs for patients.
3 January 2026
Breakthrough study finds traditional Medicinal Fungus shows strong antidiabetic potential

A new peer-reviewed study has revealed that Sanghuangporus quercicola, a medicinal fungus long used in traditional practices across Asia, produces significantly varied secondary metabolites under different cultivation conditions, with notable in vitro antidiabetic activity emerging from the analyses.

2 January 2026
Career for MPharm, MTech, MSc at the Department of Biotherapeutics Research, MAHE
M.Sc. (Biotechnology / Biochemistry / Microbiology / Molecular Biology/Genome Engineering/ Medical Biotechnology/ Biomedical Science / Life Science), M.Tech. (Biotechnology / Biomedical Engineering), M.Pharm. with first class.
2 January 2026
Interview for MPharm, MSc, MTech or PhD in biofuel production project at Indian Institute of Technology
Ph.D. or equivalent degree OR MVSc/ M.Pharm/ ME/ M.Tech with atleast 1 research paper in Science Citation Indexed (SCI) Journal
2 January 2026
Fellowship opportunities in Nanomedicine Research Laboratory for Pharma candidates
Masters Degree in Pharmaceutics or Pharmaceutical Sciences (First-class) from a recognized university. The candidate will be eligible to apply for the Ph.D. position next semester.